JTCS Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kreter, B.
Right arrow Articles by Woods, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kreter, B.
Right arrow Articles by Woods, M.

The Journal of Thoracic and Cardiovascular Surgery, Vol 104, 590-599, Copyright © 1992 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Antibiotic prophylaxis for cardiothoracic operations. Meta-analysis of thirty years of clinical trials

B Kreter and M Woods
Department of Anti-Infectives, Bristol-Myers Squibb U.S. Pharmaceutical Division, Princeton, N.J. 08543-4500.

Antistaphylococcal penicillins and first-generation cephalosporins have traditionally been the prophylactic antibiotics of choice for patients undergoing cardiothoracic operations. Recently published studies have claimed improved outcomes with respect to postoperative wound infection when second-generation cephalosporins were used for prophylaxis. The purpose of this study was to critically review the infectious outcomes of prospective, randomized, and controlled studies of cardiothoracic surgery prophylaxis by means of meta-analytic techniques. For each of 28 studies meeting the meta-analysis entry criteria, odds ratios with 95% confidence intervals were calculated to compare the prophylactic efficacy of the antibiotic regimens. Odds ratios were then pooled, and a summary odds ratio was calculated for each pairing of antibiotic treatments. Placebo-controlled trials of cardiothoracic prophylaxis demonstrated a consistent benefit to the administration of antibiotic prophylaxis, with an approximate fivefold reduction in wound infection rate. The second-generation cephalosporins, cefamandole and cefuroxime, performed better than cefazolin, with an approximate one and one-half- fold reduction in wound infection rate. Administration of prophylaxis beyond 48 hours was not associated with improved infectious outcomes.


This article has been cited by other articles:


Home page
 Card Surg AdultHome page
Z. I. Khalpey, R. B. Ganim, and J. D. Rawn
Postoperative Care of Cardiac Surgery Patients
Card. Surg. Adult, January 1, 2008; 3(2008): 465 - 486.
[Full Text]

Home page
 Card Surg AdultHome page
E. Gongora and T. M. Sundt III
Myocardial Revascularization with Cardiopulmonary Bypass
Card. Surg. Adult, January 1, 2008; 3(2008): 599 - 632.
[Full Text]

Home page
 HeartHome page
K. Dhadwal, S. Al-Ruzzeh, T. Athanasiou, M. Choudhury, P. Tekkis, P. Vuddamalay, H. Lyster, M. Amrani, and S. George
Comparison of clinical and economic outcomes of two antibiotic prophylaxis regimens for sternal wound infection in high-risk patients following coronary artery bypass grafting surgery: a prospective randomised double-blind controlled trial
Heart, September 1, 2007; 93(9): 1126 - 1133.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
R. Engelman, D. Shahian, R. Shemin, T. S. Guy, D. Bratzler, F. Edwards, M. Jacobs, H. Fernando, and C. Bridges
The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part II: Antibiotic Choice
Ann. Thorac. Surg., April 1, 2007; 83(4): 1569 - 1576.
[Full Text] [PDF]

Home page
 MMCTSHome page
N. Durrleman and G. Massard
Thoracic incisions - general considerations
MMCTS, August 10, 2006; 2006(0810): 1420.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
A. D. Caffarelli, J. P. Holden, E. J. Baron, H. J.M. Lemmens, H. D'Souza, V. Yau, C. Olcott IV, B. A. Reitz, D. C. Miller, and P. J.A. van der Starre
Plasma cefazolin levels during cardiovascular surgery: Effects of cardiopulmonary bypass and profound hypothermic circulatory arrest
J. Thorac. Cardiovasc. Surg., June 1, 2006; 131(6): 1338 - 1343.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
F. H. Edwards, R. M. Engelman, P. Houck, D. M. Shahian, and C. R. Bridges
The Society of Thoracic Surgeons Practice Guideline Series: Antibiotic Prophylaxis in Cardiac Surgery, Part I: Duration
Ann. Thorac. Surg., January 1, 2006; 81(1): 397 - 404.
[Full Text] [PDF]

Home page
 Arch SurgHome page
D. W. Bratzler, P. M. Houck, C. Richards, L. Steele, E. P. Dellinger, D. E. Fry, C. Wright, A. Ma, K. Carr, and L. Red
Use of Antimicrobial Prophylaxis for Major Surgery: Baseline Results From the National Surgical Infection Prevention Project
Arch Surg, February 1, 2005; 140(2): 174 - 182.
[Abstract] [Full Text] [PDF]

Home page
 Card Surg AdultHome page
Y. J. Woo and T. J. Gardner
Myocardial Revascularization with Cardiopulmonary Bypass
Card. Surg. Adult, January 1, 2003; 2(2003): 581 - 607.
[Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
R. Finkelstein, G. Rabino, T. Mashiah, Y. Bar-El, Z. Adler, V. Kertzman, O. Cohen, and S. Milo
Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections
J. Thorac. Cardiovasc. Surg., February 1, 2002; 123(2): 326 - 332.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
M. Carrier, R. Marchand, P. Auger, Y. Hebert, M. Pellerin, L. P. Perrault, R. Cartier, D. Bouchard, N. Poirier, and P. Page
Methicillin-resistant Staphylococcus aureus infection in a cardiac surgical unit
J. Thorac. Cardiovasc. Surg., January 1, 2002; 123(1): 40 - 44.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
T. P. Carrel, E. Eisinger, M. Vogt, and M. I. Turina
Pneumonia after cardiac surgery is predictable by tracheal aspirates but cannot be prevented by prolonged antibiotic prophylaxis
Ann. Thorac. Surg., July 1, 2001; 72(1): 143 - 148.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
S. Harbarth, M. H. Samore, D. Lichtenberg, and Y. Carmeli
Prolonged Antibiotic Prophylaxis After Cardiovascular Surgery and Its Effect on Surgical Site Infections and Antimicrobial Resistance
Circulation, June 27, 2000; 101(25): 2916 - 2921.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
K. A. Eagle, R. A. Guyton, R. Davidoff, G. A. Ewy, J. Fonger, T. J. Gardner, J. P. Gott, H. C. Herrmann, R. A. Marlow, W. C. Nugent, et al.
ACC/AHA guidelines for coronary artery bypass graft surgery: A report of the American College of Cardiology/ American Heart Association task force on Practice Guidelines (Committee to revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery)
J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1262 - 1347.
[Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
U. Niederhauser, M. Vogt, P. Vogt, M. Genoni, A. Kunzli, and M. I. Turina
CARDIAC SURGERY IN A HIGH-RISK GROUP OF PATIENTS: IS PROLONGED POSTOPERATIVE ANTIBIOTIC PROPHYLAXIS EFFECTIVE?.
J. Thorac. Cardiovasc. Surg., August 1, 1997; 114(2): 162 - 168.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
S. B. Mossad, J. M. Serkey, D. L. Longworth, D. M. Cosgrove III, and S. M. Gordon
Coagulase-Negative Staphylococcal Sternal Wound Infections After Open Heart Operations
Ann. Thorac. Surg., February 1, 1997; 63(2): 395 - 401.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1992 by The American Association for Thoracic Surgery.